-
1
-
-
0036605095
-
Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts
-
Kanekura T, Chen X, Kanzaki T. Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts. Int J Cancer. 2002;99:520-8.
-
(2002)
Int. J. Cancer
, vol.99
, pp. 520-528
-
-
Kanekura, T.1
Chen, X.2
Kanzaki, T.3
-
2
-
-
0028795147
-
The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily
-
Biswas C, Zhang Y, DeCastro R, Guo H, Nakamura T, Kataoka H, et al. The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res. 1995;55:434-9.
-
(1995)
Cancer Res.
, vol.55
, pp. 434-439
-
-
Biswas, C.1
Zhang, Y.2
DeCastro, R.3
Guo, H.4
Nakamura, T.5
Kataoka, H.6
-
3
-
-
0032443309
-
Tumor-derived EMMPRIN (extracellular matrix metalloproteinase inducer) stimulates collagenase transcription through MAPK p38
-
Lim M, Martinez T, Jablons D, Cameron R, Guo H, Toole B, et al. Tumor-derived EMMPRIN (extracellular matrix metalloproteinase inducer) stimulates collagenase transcription through MAPK p38. FEBS Lett. 1998;441:88-92.
-
(1998)
FEBS Lett.
, vol.441
, pp. 88-92
-
-
Lim, M.1
Martinez, T.2
Jablons, D.3
Cameron, R.4
Guo, H.5
Toole, B.6
-
4
-
-
0037392052
-
Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells
-
Yang JM, Xu Z, Wu H, Zhu H, Wu X, Hait WN. Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells. Mol Cancer Res. 2003;1:420-7.
-
(2003)
Mol. Cancer Res.
, vol.1
, pp. 420-427
-
-
Yang, J.M.1
Xu, Z.2
Wu, H.3
Zhu, H.4
Wu, X.5
Hait, W.N.6
-
5
-
-
0036066346
-
Extracellular matrix metalloproteinase inducer (EMMPRIN) is induced upon monocyte differentiation and is expressed in human atheroma
-
Major T, Liang L, Lu X. Extracellular matrix metalloproteinase inducer (EMMPRIN) is induced upon monocyte differentiation and is expressed in human atheroma. Arterioscler Thromb Vasc Biol. 2002;22:1200-7.
-
(2002)
Arterioscler Thromb. Vasc. Biol.
, vol.22
, pp. 1200-1207
-
-
Major, T.1
Liang, L.2
Lu, X.3
-
6
-
-
20144389430
-
Upstream regulation of matrix metalloproteinase by EMM-PRIN; extracellular matrix metalloproteinase inducer in advanced atherosclerotic plaque
-
Yoon YW, Kwon HM, Hwang KC, Choi EY, Hong BK, Kim D, et al. Upstream regulation of matrix metalloproteinase by EMM-PRIN; extracellular matrix metalloproteinase inducer in advanced atherosclerotic plaque. Atherosclerosis. 2005;180:37-44.
-
(2005)
Atherosclerosis
, vol.180
, pp. 37-44
-
-
Yoon, Y.W.1
Kwon, H.M.2
Hwang, K.C.3
Choi, E.Y.4
Hong, B.K.5
Kim, D.6
-
7
-
-
23244451640
-
Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK
-
Hagemann T, Wilson J, Kulbe H. Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK. J Immunol. 2005;175:1197-205.
-
(2005)
J. Immunol.
, vol.175
, pp. 1197-1205
-
-
Hagemann, T.1
Wilson, J.2
Kulbe, H.3
-
8
-
-
30944460859
-
C-reactive protein-induced upregulation of extracellular matrix metalloproteinase inducer in macrophages: Inhibitory effect of fluvastatin
-
Abe N, Osanai T, Fujiwara T, Kameda K, Matsunaga T, Okumura K. C-reactive protein-induced upregulation of extracellular matrix metalloproteinase inducer in macrophages: inhibitory effect of fluvastatin. Life Sci. 2006;78:1021-8.
-
(2006)
Life Sci.
, vol.78
, pp. 1021-1028
-
-
Abe, N.1
Osanai, T.2
Fujiwara, T.3
Kameda, K.4
Matsunaga, T.5
Okumura, K.6
-
9
-
-
33644861241
-
Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: Implications in acute myocardial infarction
-
Schmidt R, Bultmann A, Ungerer M. Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction. Circulation. 2006;113:834-41.
-
(2006)
Circulation
, vol.113
, pp. 834-841
-
-
Schmidt, R.1
Bultmann, A.2
Ungerer, M.3
-
10
-
-
0037180771
-
Inflammation in atherosclerosis
-
Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868-74.
-
(2002)
Nature
, vol.420
, pp. 868-874
-
-
Libby, P.1
-
11
-
-
33749102228
-
Atherosclerosis as an inflammatory disease: Implications for therapy
-
Eldika N, Yerra L, Chi DS, Krishnaswamy G. Atherosclerosis as an inflammatory disease: implications for therapy. Front Biosci. 2004;9:2764-77.
-
(2004)
Front Biosci.
, vol.9
, pp. 2764-2777
-
-
Eldika, N.1
Yerra, L.2
Chi, D.S.3
Krishnaswamy, G.4
-
12
-
-
0034846702
-
Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation
-
McEver RP. Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation. Thromb Haemost. 2001;86:746-56.
-
(2001)
Thromb. Haemost.
, vol.86
, pp. 746-756
-
-
McEver, R.P.1
-
13
-
-
43049157965
-
Cyclooxygenase and prostaglandin synthases in atherosclerosis: Recent insights and future perspectives
-
Cipollone F, Cicolini G, Bucci M. Cyclooxygenase and prostaglandin synthases in atherosclerosis: recent insights and future perspectives. Pharmacol Ther. 2008;118:161-80.
-
(2008)
Pharmacol. Ther.
, vol.118
, pp. 161-180
-
-
Cipollone, F.1
Cicolini, G.2
Bucci, M.3
-
16
-
-
0037769717
-
Cyclooxygenase-2 in human pathological disease
-
Koki A, Khan NK, Woerner BM, Dannenberg AJ, Olson L, Seibert K, et al. Cyclooxygenase-2 in human pathological disease. Adv Exp Med Biol. 2002;507:177-84.
-
(2002)
Adv. Exp. Med. Biol.
, vol.507
, pp. 177-184
-
-
Koki, A.1
Khan, N.K.2
Woerner, B.M.3
Dannenberg, A.J.4
Olson, L.5
Seibert, K.6
-
17
-
-
0035928784
-
Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaquesasa basis of prostaglandin E (2)-dependent plaque instability
-
Cipollone F, Prontera C, Pini B, Marini M, Fazia M, De Cesare D, et al. Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaquesasa basis of prostaglandin E (2)-dependent plaque instability. Circulation. 2001;104:921-7.
-
(2001)
Circulation
, vol.104
, pp. 921-927
-
-
Cipollone, F.1
Prontera, C.2
Pini, B.3
Marini, M.4
Fazia, M.5
De Cesare, D.6
-
18
-
-
0037465733
-
Suppression of the functionally coupled cyclooxygenase-2/prostaglandin E synthase as a basis of simvastatindependent plaque stabilization in humans
-
Cipollone F, Fazia M, Iezzi A, Zucchelli M, Pini B, De Cesare D, et al. Suppression of the functionally coupled cyclooxygenase-2/prostaglandin E synthase as a basis of simvastatindependent plaque stabilization in humans. Circulation. 2003;107:1479-85.
-
(2003)
Circulation
, vol.107
, pp. 1479-1485
-
-
Cipollone, F.1
Fazia, M.2
Iezzi, A.3
Zucchelli, M.4
Pini, B.5
De Cesare, D.6
-
19
-
-
12144289317
-
Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity
-
Cipollone F, Fazia M, Iezzi A, Pini B, Cuccurullo C, Zucchelli M, et al. Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity. Circulation. 2004;109:1482-8.
-
(2004)
Circulation
, vol.109
, pp. 1482-1488
-
-
Cipollone, F.1
Fazia, M.2
Iezzi, A.3
Pini, B.4
Cuccurullo, C.5
Zucchelli, M.6
-
20
-
-
0034688194
-
The heart outcomes prevention evaluation study investigators effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
-
Yusuf S, Sleiht P, Pogue J. The Heart Outcomes Prevention Evaluation Study Investigators Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000;342:145-53.
-
(2000)
N. Engl. J. Med.
, vol.342
, pp. 145-153
-
-
Yusuf, S.1
Sleiht, P.2
Pogue, J.3
-
21
-
-
0037160968
-
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol
-
DOI 10.1016/S0140-6736(02)08089-3
-
Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359:995-1003. (Pubitemid 34286536)
-
(2002)
Lancet
, vol.359
, Issue.9311
, pp. 995-1003
-
-
Dahlof, B.1
Devereux, R.B.2
Kjeldsen, S.E.3
Julius, S.4
Beevers, G.5
De Faire, U.6
Fyhrquist, F.7
Ibsen, H.8
Kristiansson, K.9
Lederballe-Pedersen, O.10
Lindholm, L.H.11
Nieminen, M.S.12
Omvik, P.13
Oparil, S.14
Wedel, H.15
-
22
-
-
0042330455
-
Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: Randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)
-
Fox K. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet. 2003;362:782-7.
-
(2003)
Lancet
, vol.362
, pp. 782-787
-
-
Fox, K.1
-
23
-
-
0034724305
-
Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: Potential implications for inflammation and plaque instability
-
Schieffer B, Schieffer E, Hilfiker-Kleiner D. Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Circulation. 2000;101:1372-8.
-
(2000)
Circulation
, vol.101
, pp. 1372-1378
-
-
Schieffer, B.1
Schieffer, E.2
Hilfiker-Kleiner, D.3
-
24
-
-
0033956858
-
Induction of cyclooxygenase-2 by angiotensin II in cultured rat vascular smooth muscle cells
-
Ohnaka K, Numaguchi K, Yamakawa T, Inagami T. Induction of cyclooxygenase-2 by angiotensin II in cultured rat vascular smooth muscle cells. Hypertension. 2000;35:68-75. (Pubitemid 30054239)
-
(2000)
Hypertension
, vol.35
, Issue.1
, pp. 68-75
-
-
Ohnaka, K.1
Numaguchi, K.2
Yamakawa, T.3
Inagami, T.4
-
25
-
-
0028826061
-
Role of angiotensin II and prostaglandin E2 in regulating cardiac fibroblast collagen turnover
-
Brilla CG, Zhou G, Rupp H, Maisch B, Weber KT. Role of angiotensin II and prostaglandin E2 in regulating cardiac fibroblast collagen turnover. Am J Cardiol. 1995;76:8D-13D.
-
(1995)
Am. J. Cardiol.
, vol.76
-
-
Brilla, C.G.1
Zhou, G.2
Rupp, H.3
Maisch, B.4
Weber, K.T.5
-
26
-
-
33847689914
-
Optimized THP-1 differentiation is required for the detection of responses to weak stimuli
-
Park EK, Jung HS, Yang HI, Yoo MC, Kim C, Kim KS. Optimized THP-1 differentiation is required for the detection of responses to weak stimuli. Inflamm Res. 2007;56:45-50.
-
(2007)
Inflamm. Res.
, vol.56
, pp. 45-50
-
-
Park, E.K.1
Jung, H.S.2
Yang, H.I.3
Yoo, M.C.4
Kim, C.5
Kim, K.S.6
-
27
-
-
0034603775
-
Inhibition of early atherogenesis by losartan in monkeys with dietinduced hypercholesterolemia
-
Strawn WB, Chappell MC, Dean RH, Kivlighn S, Ferrario CM. Inhibition of early atherogenesis by losartan in monkeys with dietinduced hypercholesterolemia. Circulation. 2000;101:1586-93.
-
(2000)
Circulation
, vol.101
, pp. 1586-1593
-
-
Strawn, W.B.1
Chappell, M.C.2
Dean, R.H.3
Kivlighn, S.4
Ferrario, C.M.5
-
28
-
-
47649093164
-
Anti-atherosclerotic properties of telmisartan in advanced atherosclerotic lesions in apolipoprotein E deficient mice
-
Blessing E, Preusch M, Kranzhofer R, Kinscherf R, Marx N, Rosenfeld ME, et al. Anti-atherosclerotic properties of telmisartan in advanced atherosclerotic lesions in apolipoprotein E deficient mice. Atherosclerosis. 2008;199:295-303.
-
(2008)
Atherosclerosis
, vol.199
, pp. 295-303
-
-
Blessing, E.1
Preusch, M.2
Kranzhofer, R.3
Kinscherf, R.4
Marx, N.5
Rosenfeld, M.E.6
-
29
-
-
30044437012
-
Transiently heightened angiotensin II has distinct effects on atherosclerosis and aneurysm formation in hyperlipidemic mice
-
Ayabe N, Babaev VR, Tang Y, Tanizawa T, Fogo AB, Linton MF, et al. Transiently heightened angiotensin II has distinct effects on atherosclerosis and aneurysm formation in hyperlipidemic mice. Atherosclerosis. 2006;184:312-21.
-
(2006)
Atherosclerosis
, vol.184
, pp. 312-321
-
-
Ayabe, N.1
Babaev, V.R.2
Tang, Y.3
Tanizawa, T.4
Fogo, A.B.5
Linton, M.F.6
-
30
-
-
0034129997
-
Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice
-
Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest. 2000;105:1605-12.
-
(2000)
J. Clin. Invest.
, vol.105
, pp. 1605-1612
-
-
Daugherty, A.1
Manning, M.W.2
Cassis, L.A.3
-
31
-
-
0037312548
-
Matrix metalloproteinases and coronary artery diseases
-
Ikeda U, Shimada K. Matrix metalloproteinases and coronary artery diseases. Clin Cardiol. 2003;26:55-9.
-
(2003)
Clin. Cardiol.
, vol.26
, pp. 55-59
-
-
Ikeda, U.1
Shimada, K.2
-
32
-
-
19944434168
-
Angiotensin II induces MMP-2 in a p47phox-dependent manner
-
Luchtefeld M, Grote K, Grothusen C, Bley S, Bandlow N, Selle T, et al. Angiotensin II induces MMP-2 in a p47phox-dependent manner. Biochem Biophys Res Commun. 2005;328:183-8.
-
(2005)
Biochem. Biophys. Res. Commun.
, vol.328
, pp. 183-188
-
-
Luchtefeld, M.1
Grote, K.2
Grothusen, C.3
Bley, S.4
Bandlow, N.5
Selle, T.6
-
33
-
-
40849140684
-
Angiotensin II induces matrix metalloproteinase-9 expression via a nuclear factor-kappaB-dependent pathway in vascular smooth muscle cells
-
Guo RW, Yang LX, Wang H, Liu B, Wang L. Angiotensin II induces matrix metalloproteinase-9 expression via a nuclear factor-kappaB-dependent pathway in vascular smooth muscle cells. Regul Pept. 2008;147:37-44.
-
(2008)
Regul Pept
, vol.147
, pp. 37-44
-
-
Guo, R.W.1
Yang, L.X.2
Wang, H.3
Liu, B.4
Wang, L.5
-
34
-
-
0030871687
-
COX-1 and COX-2 tissue expression: Implications and predictions
-
Crofford LJ. COX-1 and COX-2 tissue expression: implications and predictions. J Rheumatol Suppl. 1997;49:15-9.
-
(1997)
J. Rheumatol. Suppl.
, vol.49
, pp. 15-19
-
-
Crofford, L.J.1
-
35
-
-
17144454444
-
Coexpression of cyclooxygenase-2 and matrix metalloproteinases in human aortic atherosclerotic lesions
-
Hong BK, Kwon HM, Lee BK, Kim D, Kim IJ, Kang SM, et al. Coexpression of cyclooxygenase-2 and matrix metalloproteinases in human aortic atherosclerotic lesions. Yonsei Med J. 2000;41:82-8.
-
(2000)
Yonsei Med. J.
, vol.41
, pp. 82-88
-
-
Hong, B.K.1
Kwon, H.M.2
Lee, B.K.3
Kim, D.4
Kim, I.J.5
Kang, S.M.6
-
36
-
-
0037117652
-
Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice
-
Burleigh ME, Babaev VR, Oates JA, Harris RC, Gautam S, Riendeau D, et al. Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice. Circulation. 2002;105:1816-23.
-
(2002)
Circulation
, vol.105
, pp. 1816-1823
-
-
Burleigh, M.E.1
Babaev, V.R.2
Oates, J.A.3
Harris, R.C.4
Gautam, S.5
Riendeau, D.6
-
37
-
-
23644460499
-
Cyclooxygenase-2 promotes early atherosclerotic lesion formation in ApoE-deficient and C57BL/6 mice
-
Burleigh ME, Babaev VR, Yancey PG, Major AS, McCaleb JL, Oates JA, et al. Cyclooxygenase-2 promotes early atherosclerotic lesion formation in ApoE-deficient and C57BL/6 mice. J Mol Cell Cardiol. 2005;39:443-52.
-
(2005)
J. Mol. Cell. Cardiol.
, vol.39
, pp. 443-452
-
-
Burleigh, M.E.1
Babaev, V.R.2
Yancey, P.G.3
Major, A.S.4
McCaleb, J.L.5
Oates, J.A.6
-
38
-
-
0031036521
-
Stimulation of matrix metalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells
-
Guo H, Zucker S, Gordon MK, Toole BP, Biswas C. Stimulation of matrix metalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells. J Biol Chem. 1997;272:24-7.
-
(1997)
J. Biol. Chem.
, vol.272
, pp. 24-27
-
-
Guo, H.1
Zucker, S.2
Gordon, M.K.3
Toole, B.P.4
Biswas, C.5
-
39
-
-
0034680366
-
A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure
-
Spinale FG, Coker ML, Heung LJ. A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure. Circulation. 2000;102:1944-9.
-
(2000)
Circulation
, vol.102
, pp. 1944-1949
-
-
Spinale, F.G.1
Coker, M.L.2
Heung, L.J.3
-
40
-
-
0034127659
-
Myocardial matrix degradation and matrix metalloproteinase activation in the failing heart: A potential therapeutic target
-
Spinale FG, Coker ML, Bond BR, Zellner JL. Myocardial matrix degradation and matrix metalloproteinase activation in the failing heart: a potential therapeutic target. Circ Res. 2000;46:225-38.
-
(2000)
Circ. Res.
, vol.46
, pp. 225-238
-
-
Spinale, F.G.1
Coker, M.L.2
Bond, B.R.3
Zellner, J.L.4
-
41
-
-
1842527873
-
Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial
-
Brown DL, Desai KK, Vakili BA. Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial. Arterioscler Thromb Vasc Biol. 2004;24:733-8.
-
(2004)
Arterioscler Thromb. Vasc. Biol.
, vol.24
, pp. 733-738
-
-
Brown, D.L.1
Desai, K.K.2
Vakili, B.A.3
|